| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |